How stress can mask the symptoms of chronic disease
UC expert featured in New York Times article
Ongoing research has found stress is closely linked with many chronic diseases including asthma, heart disease, arthritis, lupus and inflammatory bowel disease. At the same time, many issues caused by stress, like headaches and blood pressure problems, can also be symptoms of chronic illnesses.
The University of Cincinnati's Charles Hattemer, MD, spoke with the New York Times on how stress can play a part in triggering chronic diseases.
Hattemer, professor, division chief of cardiovascular health and disease and Mabel Stearns Stonehill Endowed Chair in the Department of Internal Medicine in UC's College of Medicine, and a UC Health physician, said stress naturally kickstarts the fight-or-flight response.
When people are stressed for weeks or months, their bodies may be unable to maintain other functions. Hattemer said stress hormones can also chronically elevate blood pressure or increase plaque deposits, which can damage the heart over time.
Read the New York Times article.
Featured photo at top courtesy of Pixabay.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.